Zoster oticus (Ramsay Hunt syndrome) facial weakness - Causes, Treatment & When to See a Doctor

What is Zoster oticus (Ramsay Hunt syndrome) facial weakness?

Zoster oticus, more commonly known as **Ramsay Hunt syndrome (RHS)**, is a neurological disorder caused by the re‑activation of the varicella‑zoster virus (VZV) in the facial nerve (cranial nerve VII) near the ear. When the virus reactivates, it can inflame the facial nerve and the adjacent vestibulocochlear nerve (cranial nerve VIII), leading to a combination of facial weakness or paralysis, ear pain, and a characteristic rash in the ear canal or on the pinna.

Facial weakness in RHS typically presents as an acute, often severe, drooping of one side of the face, similar to Bell’s palsy, but it is usually accompanied by other distinctive signs such as vesicular eruptions in or around the ear and hearing or balance problems. Early recognition is crucial because prompt antiviral and anti‑inflammatory therapy can dramatically improve outcomes and reduce the risk of permanent facial nerve damage.

Common Causes

Ramsay Hunt syndrome itself is caused by VZV reactivation, but several factors can predispose a person to develop the condition or mimic its presentation. Below are 8‑10 common conditions or risk factors associated with facial weakness in the setting of Zoster oticus:

• Varicella‑zoster virus reactivation – the primary cause of RHS.
• Immunosuppression – HIV infection, organ transplantation, chemotherapy, or chronic steroid use increase the risk.
• Advanced age – incidence rises sharply after age 60.
• Stress or severe illness – can trigger viral reactivation.
• Diabetes mellitus – impairs immune function and nerve health.
• Previous shingles (herpes zoster) infection – indicates latent VZV in the sensory ganglia.
• Trauma to the ear or face – may disrupt the nerve’s protective sheath, facilitating viral spread.
• Other cranial nerve infections – e.g., herpes simplex virus causing similar facial paresis.
• Autoimmune disorders – such as sarcoidosis, which can also cause facial nerve palsy.
• Congenital facial nerve malformations – rare, but can be confused with RHS when an ear rash appears.

Associated Symptoms

Facial weakness rarely occurs in isolation with RHS. The following symptoms frequently accompany the paresis, helping clinicians differentiate RHS from other causes of facial palsy:

• Ear pain (otalgia) – often severe and precedes the rash.
• Vesicular rash – clusters of fluid‑filled blisters on the external ear, ear canal, or sometimes on the palate.
• Hearing loss – ranging from mild to profound, usually on the affected side.
• Tinnitus – ringing or buzzing in the ear.
• Vertigo or disequilibrium – due to involvement of the vestibular portion of cranial nerve VIII.
• Hyperacusis – increased sensitivity to ordinary sounds, caused by stapedius muscle paralysis.
• Dry eye or decreased tear production – because the facial nerve also innervates lacrimal glands.
• Altered taste sensation – loss of taste on the anterior two‑thirds of the tongue.
• Fever and malaise – systemic signs of viral infection.

When to See a Doctor

Facial weakness that develops suddenly deserves prompt medical attention, especially when any of the following are present:

• Rapid onset of facial droop within 48 hours.
• Severe ear pain or a rash in or around the ear.
• Hearing loss, ringing, or vertigo on the same side.
• Difficulty closing the eye, leading to eye dryness or irritation.
• Loss of taste or sensation in the front two‑thirds of the tongue.
• Fever, headache, or general feeling of illness.
• Any signs of facial weakness that do not improve within 72 hours.

Because early antiviral therapy (ideally within 72 hours of symptom onset) improves the chance of full recovery, you should seek care as soon as possible.

Diagnosis

Diagnosing RHS involves a combination of clinical evaluation and targeted investigations.

Clinical Examination

• History – onset, severity of pain, rash appearance, hearing changes, and immunization status.
• Physical exam – assessment of facial nerve function (House‑Brackmann scale), inspection of the ear canal for vesicles, and evaluation of hearing and balance.
• Neurologic exam – to rule out central causes of facial weakness such as stroke.

Laboratory & Imaging Tests

• Polymerase chain reaction (PCR) of vesicle fluid – detects VZV DNA, confirming viral reactivation.
• Serology – VZV IgM/IgG may support the diagnosis but is less specific.
• Audiometry – quantifies hearing loss.
• Electronystagmography (ENG) or videonystagmography (VNG) – evaluates vestibular function when vertigo is present.
• Magnetic resonance imaging (MRI) with contrast – useful to exclude alternative causes like tumor or stroke and to visualize facial nerve enhancement.

Differential Diagnosis

Conditions that can mimic RHS include Bell’s palsy, otitis media, acoustic neuroma, Lyme disease, and stroke. A thorough exam and appropriate tests help rule out these alternatives.

Treatment Options

Effective treatment combines antiviral medication, corticosteroids, and supportive care. Early initiation—ideally within three days of onset—is associated with the best functional outcomes.

Medical Therapy

• Antiviral agents – Oral acyclovir (800 mg five times daily), valacyclovir (1 g three times daily), or famciclovir (500 mg three times daily) for 7–10 days. These reduce viral replication and limit nerve damage.
• Corticosteroids – Prednisone 60 mg daily (or equivalent) for 5 days followed by a taper over 10‑14 days. Steroids reduce inflammation and edema around the facial nerve.
• Analgesics – NSAIDs or acetaminophen for ear pain; consider gabapentin for neuropathic pain if needed.
• Antiemetics – If vertigo is severe, medications such as meclizine can improve comfort.

Supportive & Home Care

• **Eye protection** – Use lubricating eye drops during the day and ointment at night; taping the eyelid closed while sleeping prevents corneal drying.
• **Facial exercises** – Gentle, guided facial stretching can maintain muscle tone and improve recovery.
• **Heat packs** – Applied to the ear may relieve pain, but avoid excessive heat that could worsen inflammation.
• **Hydration and nutrition** – Adequate fluids and a balanced diet support immune function.
• **Vaccination** – If you have not received the shingles vaccine (Shingrix), discuss it with your physician after recovery to reduce future reactivations.

Follow‑up Care

Patients should be re‑evaluated in 1–2 weeks to assess facial nerve recovery, hearing status, and pain control. Persistent weakness after 3 months may benefit from physical therapy, botulinum toxin injections (for synkinesis), or surgical decompression in rare severe cases.

Prevention Tips

While you cannot completely eliminate the risk of VZV reactivation, the following measures can lower the likelihood or lessen severity:

• Shingles vaccination – Shingrix is >90 % effective at preventing shingles and post‑herpetic complications in adults 50 years and older (CDC, 2023).
• Maintain a healthy immune system – Balanced diet, regular exercise, adequate sleep, and stress‑management techniques.
• Control chronic conditions – Keep diabetes, hypertension, and HIV well‑controlled with appropriate medication.
• Limit steroid or immunosuppressive use – Use the lowest effective dose and discuss prophylactic antivirals with your physician if you require long‑term immunosuppression.
• Avoid smoking and excess alcohol – Both impair immune response and nerve health.
• Prompt treatment of ear infections – Early antibiotics for bacterial otitis media reduce secondary inflammation that might trigger VZV reactivation.

Emergency Warning Signs

Key Take‑aways

Ramsay Hunt syndrome is a medical emergency that combines a painful ear rash with facial nerve paralysis. Early antiviral and steroid therapy dramatically improves the chance of full recovery, while delayed treatment can lead to permanent facial weakness, hearing loss, and chronic pain. Recognizing the hallmark rash, ear pain, and associated auditory or vestibular symptoms, and seeking care promptly, are essential steps for any patient experiencing these signs.

**References**

• Mayo Clinic. “Ramsay Hunt syndrome.” Updated 2023. https://www.mayoclinic.org
• Centers for Disease Control and Prevention. “Shingles (Herpes Zoster) Vaccination.” 2023. https://www.cdc.gov
• National Institutes of Health. “Varicella Zoster Virus Infections.” NIH NeuroBioBank, 2022.
• World Health Organization. “Herpes Zoster: Epidemiology and Prevention.” WHO Technical Report Series, 2022.
• Cleveland Clinic. “Facial nerve (Bell’s) palsy vs. Ramsay Hunt syndrome.” 2024. https://my.clevelandclinic.org
• American Academy of Otolaryngology—Head and Neck Surgery. Clinical practice guideline: “Management of Herpes Zoster Oticus.” 2021.